Kaiser Permanente’s 2-1-1 pre-exposure prophylaxis (PrEP) program shows event-driven dosing works.
Will Oregon’s new bill allowing PrEP without a doctor's prescription improve upon similar laws in California and Colorado?
In sub-Saharan Africa, herbalists and spiritual healers are working closely with researchers to help reduce HIV transmission in rural communities.
While findings from the high-profile AMP studies have excited scientists, they’re only one of a wide range of bNAb avenues currently being pursued.
Beyond the big-picture improvements, a closer look at the data reveals stark racial and geographic disparities in HIV incidence and prevalence.
The findings add to evidence that injectable PrEP could ultimately have greater real-world efficacy than daily oral PrEP in many populations, thanks to better adherence.
New findings from the Antibody-Mediated Prevention (AMP) studies indicate that broadly neutralizing antibodies can work, but several will need to be used in combination.
A new expert consensus statement explores how providers can give birthing parents who are living with HIV the information they need to decide for themselves.
Developing a vaccine for HIV presents more challenges than creating one for COVID-19, but research that has led to the new COVID vaccines can help bring an HIV vaccine closer to reality.
‘PrEP for Women Too’ Campaign Aims to Bring This Empowering HIV Prevention Tool to More Black and Latinx Women
Despite PrEP being safe to take for people of all genders, there’s still a lag in uptake among cisgender women.
Sex is a vital part of human life—and clinicians should be asking about it.